RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. RedChip has helped hundreds of companies achieve their capital markets goals and has been ranked by Inc. Magazine as one of the fastest growing privately held investor relations firms in the U.S. #finance #capitalmarkets #investorrelations
RedChip Companies
Financial Services
Maitland, Florida 3,836 followers
Discovering Tomorrow’s Blue Chips Today™
About us
RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. Founded in 1992, and headquartered in Orlando, Florida, with affiliates in New York and Pittsburgh, RedChip has helped hundreds of companies achieve their capital markets goals. RedChip has been ranked by Inc. magazine as one of the fastest growing privately held investor relations firms in the U.S. RedChip represents 70+ emerging growth companies in a variety of industries including Business Services, Esports Gaming, Consumer Goods, High Tech, Industrials, Mining and Minerals, Electric Vehicles, Drones, Crypto, and EdTech. Our unique platform combines traditional investor relations services with multi-media marketing. Our weekly TV show, the RedChip Money Report®, which airs on Bloomberg 7 P.M. Eastern every Saturday, delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies. Our traditional investor relations platform includes retail and institutional road-shows in 10 U.S. cities, press-release writing, strategic counsels, management of quarterly conference calls, script writing, power-point presentation development, and more.
- Website
-
https://www.redchip.com/
External link for RedChip Companies
- Industry
- Financial Services
- Company size
- 11-50 employees
- Headquarters
- Maitland, Florida
- Type
- Privately Held
- Specialties
- Small-Cap Equity Research, Financial Public Relations/Investor Relations, Achieving Fair Equity Value for Public Companies, and Institutional and Retail Non-Deal Road Shows
Locations
-
Primary
Maitland, Florida 32751, US
Employees at RedChip Companies
Updates
-
🚨 OS Therapies (NYSE American: OSTX) to Present Key Phase 2b Data at Leading Osteosarcoma Conference! OS Therapies will showcase OST-HER2 trial results at MIB Agents Osteosarcoma Alliance FACTOR (June 26-28, 2025)—critical data supporting its Q2 2025 FDA BLA submission for preventing recurrent lung metastatic osteosarcoma. 💡 Why It Matters for Investors: ✅ Regulatory Momentum – Data to support FDA & global approvals. ✅ Fast-Track Status – Holds Rare & Pediatric Disease, Fast Track & Orphan Drug designations. ✅ Potential Windfall – FDA approval before Sept 30, 2026, could grant a Priority Review Voucher (PRV)—recently valued at $150M. 🚀 OS Therapies is moving fast toward commercialization. 🔗 Read More: https://lnkd.in/etJFUyeZ Biotechnology Biotechnology News Antibody Drug Conjugates - ADC #RedChip #RedChat #OSTX #BiotechStocks #Immunotherapy #ADC #Investing #CancerResearch #StockMarket
-
-
📢 Trinity Biotech (Nasdaq: TRIB) Sharpens Focus on CGM with Barclays Appointment Trinity Biotech has named Barclays Capital as its exclusive financial advisor, reinforcing its strategic shift to continuous glucose monitoring (CGM) and data-driven diabetes management. 💡 Why Investors Should Watch: ✅ CGM as the Core Focus – Prioritizing innovative, user-friendly, and affordable CGM technology. ✅ Strategic Portfolio Optimization – Barclays advising on asset realignment to support CGM expansion. ✅ Strong Market Validation – Promising pre-pivotal trial data and high industry interest. 🔗 Read More: https://lnkd.in/e-szUN85 Biotechnology Biotechnology News #RedChip #RedChat #TrinityBio #BiotechStocks #CGM #DiabetesTech #Investing #HealthcareInnovation
-
-
📢 Want more details on Fathom Holdings Inc. earnings?! Fathom is hosting its Investor Webinar tomorrow at 4:15 PM EST! 🔍 What to Expect: 📊 Deep dive into Q4 & Full-Year 2024 earnings 📈 Outlook on EBITDA profitability & growth strategy 💡 Live Q&A with CEO Marco Fregenal 🔗 Register now and get insights straight from the source! https://lnkd.in/eG2kM5WJ Real Estate Real Estate Development My Home Group #EarningsCall #RealEstate #Investing #StockMarket #FinancialResults
📢 Fathom Holdings Inc. (Nasdaq: FTHM) Reports Strong Q4 & Full-Year 2024 Results Fathom Holdings Inc. delivered 24% revenue growth in Q4 2024, reaching $91.7M, with core business gross profit up 59% YoY. Despite persistent real estate market challenges, the company is on track for EBITDA profitability in Q2 2025. 💡 Key Takeaways for Investors: ✅ Brokerage Expansion: 26% YoY brokerage revenue growth to $87.7M ✅ Agent Growth: 14,300 agents, up 21% YoY ✅ Cost Efficiencies: $2M+ in anticipated annualized savings ✅ Strategic Acquisitions: My Home Group acquisition strengthens market position 📈 Outlook: Fathom aims to return to 25% annual revenue growth, leveraging higher-margin services, operational efficiencies, and targeted agent recruitment. 🔗 https://lnkd.in/eA7aU_3J Real Estate Real Estate Development #EarningsCall #RealEstate #Investing #StockMarket #FinancialResults
-
-
📢 Fathom Holdings Inc. (Nasdaq: FTHM) Reports Strong Q4 & Full-Year 2024 Results Fathom Holdings Inc. delivered 24% revenue growth in Q4 2024, reaching $91.7M, with core business gross profit up 59% YoY. Despite persistent real estate market challenges, the company is on track for EBITDA profitability in Q2 2025. 💡 Key Takeaways for Investors: ✅ Brokerage Expansion: 26% YoY brokerage revenue growth to $87.7M ✅ Agent Growth: 14,300 agents, up 21% YoY ✅ Cost Efficiencies: $2M+ in anticipated annualized savings ✅ Strategic Acquisitions: My Home Group acquisition strengthens market position 📈 Outlook: Fathom aims to return to 25% annual revenue growth, leveraging higher-margin services, operational efficiencies, and targeted agent recruitment. 🔗 https://lnkd.in/eA7aU_3J Real Estate Real Estate Development #EarningsCall #RealEstate #Investing #StockMarket #FinancialResults
-
-
🚨 $100M Boost for ONE AMAZON: A Game-Changer in Sustainable Investment 🌍 Global Edge Worldwide Fund has committed $100 million to ONE AMAZON, a pioneering initiative that transforms rainforest conservation into an investable, tech-driven model. With backing from Gorilla Technology Group (Nasdaq: GRRR) as a key technology partner and minority investor, this initiative merges AI, blockchain, and environmental intelligence to unlock the Amazon Rainforest’s economic and ecological value. 🔍 Why This Matters for Investors: ✅ Institutional Capital Commitment – $100M funding accelerates execution and scalability. ✅ Technology-Backed Monetization – Gorilla Technology Group's AI & IoT solutions enable real-time monitoring via the Internet of Forests™. ✅ Sustainable Finance Innovation – Blockchain-based ecological securities create a new asset class. 📢 "This is a financial and technological revolution, redefining how we value and protect natural capital," says Gorilla CEO Jay Chandan. 🌱 Could ONE AMAZON be the future of conservation finance? Learn more: 🔗 https://lnkd.in/ePYeWJ6i #RedChip #RedChat #GorillaTech #SmartGrid #AI #EnergyInnovation #Thailand #TechInvesting #Infrastructure
-
-
RedChip Companies reposted this
Ainos Expands AI Nose Partnership with Semiconductor Giant ASE Ainos, Inc. is collaborating with Advanced Semiconductor Engineering (ASE) to integrate AI Nose into ASE’s smart factories, enhancing air monitoring, predictive maintenance, and process optimization. 🔹 ASE is the world’s largest OSAT provider ($21B market cap, $19B annual revenue) 🔹 AI Nose to improve VOC detection & sustainability in semiconductor packaging & testing 🔹 Builds on AI Nose’s success in Japan, where it achieved 80% accuracy in VOC detection 🔹 Future expansion plans include broader AI Nose deployment & additional industrial applications This partnership unlocks new potential for AI-driven air sensing in semiconductor manufacturing. Check out Do Kim's full report and subscribe at our website to follow along! https://lnkd.in/eX33y3UK #AIMD #AI #Semiconductors #SmartManufacturing #AINose #Innovation #Investing #WTRInsights
-
🚨 Calidi Biotherapeutics (NYSE American: CLDI) Investor Webinar: Clinical Updates & Breakthroughs! 🚨 📅 Date: Monday, March 17 at 4:15 PM EST 🧬 Topic: Latest advancements in Calidi's RTNova platform and clinical progress Calidi Biotherapeutics recently announced promising preclinical data showcasing the ability of its systemic RTNova platform to deliver gene therapy payloads directly to tumors. This innovation has demonstrated tumor-selective virotherapy with robust immune activation, potentially revolutionizing treatments for advanced metastatic cancers. 💡 Why Investors Should Tune In: ✅ Breakthrough Science: A novel approach to virotherapy with systemic delivery and gene therapy applications ✅ Market Potential: Addressing a critical unmet need in metastatic cancer treatment ✅ Strategic Growth: Advancements could open doors for new partnerships and commercialization opportunities 🔗 Don’t miss out—register now! 👉 https://lnkd.in/eufnMNRA California Institute for Regenerative Medicine (CIRM) Northwestern University City of Hope The Lancet Group #RedChip #CalidiBio #CLDI #InvestorWebinar #CancerResearch #Oncology #BiotechStocks #OncolyticVirotherapy #FinancialNews
-
-
How do you value a gold miner? Gold in the ground. Nova Minerals Limited (Nasdaq: NVA) is trading at a fraction of what its assets are worth. Smart money sees the disconnect. 🚀 🔗 Get the facts: https://lnkd.in/egBJjeJx Mines and Money S&P Global Commodity Insights Commodity Insights LIVE Commodities: Iron, Steel, Copper, Metal, Gold, Silver, Rice, Wheat, Oil, Gas, Coffee, Cotton, Sugar #NovaMinerals #RedChipClient #RedChat #preciousmetals #antimony #Alaska #goldrush #Gold #MiningStocks
-
-
Stories like Steve T.'s highlight how CyPath Lung can help identify cancer risks sooner. With bioAffinity Technologies (Nasdaq: BIAF) expanding its footprint, this could be a game-changer for lung cancer diagnostics. 🔗 https://lnkd.in/e3snDk6H #RedChip #bioAffinity #BiotechNews #HealthcareNews #CapitalMarkets #FinancialNews
CyPath Lung patient Steve T. talks about "living with 'probably nothing,'" his doctor's verdict that was reinforced by the results of his CyPath Lung test after screening identified a small spot on his lung. CyPath Lung can ease patient anxiety after a positive screening and provide physicians with a clearer path forward in patient care. #CyPathLung #lungcancer #ScreeningSavesLives #lungnodule #pulmonology